The ACME Laboratories Ltd. (DSE:ACMELAB)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
81.10
+1.30 (1.63%)
At close: Feb 26, 2026
8.28%
Market Cap 17.16B
Revenue (ttm) 38.86B
Net Income (ttm) 2.56B
Shares Out 211.60M
EPS (ttm) 12.11
PE Ratio 6.70
Forward PE n/a
Dividend 3.50 (4.32%)
Ex-Dividend Date Nov 19, 2025
Volume 838,814
Average Volume 704,651
Open 79.80
Previous Close 79.80
Day's Range 79.80 - 81.40
52-Week Range 67.90 - 85.90
Beta 0.01
RSI 66.11
Earnings Date Apr 26, 2026

About The ACME Laboratories

The ACME Laboratories Ltd., a pharmaceutical company, engages in the manufacturing, marketing, and distribution of generic pharmaceutical formulation products in Bangladesh. The company offers pharmaceutical products in various therapeutic areas, such as allergic disorders, analgesic, antifribinolytic, anti-infective, antiviral, artificial sweeteners, cardiovascular, central nervous system (CNS), cough and cold, diabetes, eye care and preparations, gastroprokinetic, hepatobiliary, gastrointestinal, gynaecological, hand sanitizers, hormones and ... [Read more]

Industry Pharmaceutical Preparations
Founded 1954
Employees 9,025
Stock Exchange Dhaka Stock Exchange
Ticker Symbol ACMELAB
Full Company Profile

Financial Performance

In fiscal year 2025, The ACME Laboratories's revenue was 35.94 billion, an increase of 12.54% compared to the previous year's 31.93 billion. Earnings were 2.43 billion, a decrease of -1.12%.

Financial Statements

News

There is no news available yet.